User profiles for P Loiseau
Philippe LoiseauProfessor of Parasitology Verified email at u-psud.fr Cited by 8195 |
Strategies for prevention and treatment of Trichomonas vaginalis infections
K Bouchemal, C Bories, PM Loiseau - Clinical microbiology …, 2017 - Am Soc Microbiol
The last estimated annual incidence of Trichomonas vaginalis worldwide exceeds that of
chlamydia and gonorrhea combined. This critical review updates the state of the art on …
chlamydia and gonorrhea combined. This critical review updates the state of the art on …
[HTML][HTML] Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance
… Coïmbra ES, Libong D., Cojean S., Saint-Pierre-Chazalet M., Solgadi A., Le Moyec L.,
Duenas-Romero AM, Chaminade P. & Loiseau PMMechanism of interaction of sitamaquine with …
Duenas-Romero AM, Chaminade P. & Loiseau PMMechanism of interaction of sitamaquine with …
Carbon cycling and sequestration opportunities in temperate grasslands
JF Soussana, P Loiseau, N Vuichard… - Soil use and …, 2004 - Wiley Online Library
Temperate grasslands account for c. 20% of the land area in Europe. Carbon accumulation
in grassland ecosystems occurs mostly below ground and changes in soil organic carbon …
in grassland ecosystems occurs mostly below ground and changes in soil organic carbon …
Genetic factors in pemphigus
…, H Masmoudi, D Charron, M Zitouni, P Loiseau… - Journal of …, 2005 - Elsevier
Epidemiological studies performed in different ethnic populations and family studies, notably
based on a partial phenotype of the autoimmune process, indicate that genetic factors are …
based on a partial phenotype of the autoimmune process, indicate that genetic factors are …
Multicenter double‐blind, randomized, placebo‐controlled trial of levetiracetam as add‐on therapy in patients with refractory partial seizures
…, A Löwenthal, D Janz, E Bielen, P Loiseau… - …, 2000 - Wiley Online Library
… When the responder rate was examined, a significant difference was found between the
placebo and treatment groups (p = 0.004; Fig. 3). More patients treated with LEV 1,000 mg/d (…
placebo and treatment groups (p = 0.004; Fig. 3). More patients treated with LEV 1,000 mg/d (…
Miltefosine Induces Apoptosis-Like Death in Leishmania donovani Promastigotes
C Paris, PM Loiseau, C Bories… - Antimicrobial agents and …, 2004 - Am Soc Microbiol
Miltefosine (hexadecylphosphocholine [HePC]) has proved to be a potent oral treatment for
human visceral leishmaniasis due to Leishmania donovani. The molecular mechanisms that …
human visceral leishmaniasis due to Leishmania donovani. The molecular mechanisms that …
Antiparasitic activities of medicinal plants used in Ivory Coast
…, F Roblot, P Loiseau, C Bories, P Grellier… - Journal of …, 2004 - Elsevier
During an ethnopharmacological survey of antiparasitic medicinal plants used in Ivory Coast,
17 plants were identified and collected. Polar, non-polar and alkaloidic extracts of various …
17 plants were identified and collected. Polar, non-polar and alkaloidic extracts of various …
Newly diagnosed unprovoked epileptic seizures: presentation at diagnosis in CAROLE study
P Jallon, P Loiseau, J Loiseau… - …, 2001 - Wiley Online Library
… in a day or status epilepticus (p < 0.0001) in the first-seizure group, more localization-related
cryptogenic syndromes (p < 0.0001) and more institutions of treatment (p < 0.0001) in the …
cryptogenic syndromes (p < 0.0001) and more institutions of treatment (p < 0.0001) in the …
KIR-ligand incompatibility in the graft-versus-host direction improves outcomes after umbilical cord blood transplantation for acute leukemia
…, L Madero, M Mohty, C Ferra, F Garnier, P Loiseau… - Leukemia, 2009 - nature.com
Donor killer cell immunoglobulin-like receptor (KIR)-ligand incompatibility is associated with
decreased relapse incidence (RI) and improved leukemia-free survival (LFS) after …
decreased relapse incidence (RI) and improved leukemia-free survival (LFS) after …
[HTML][HTML] HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A,-B,-C,-DRB1, or-DQB1 is strongly associated with …
P Loiseau, M Busson, ML Balere, A Dormoy… - Biology of blood and …, 2007 - Elsevier
… As illustrated in Figure 1, the donor-recipient pairs with 0 or 1 mismatch had the same risk
of severe aGVHD (P = .5), which was lower than pairs with >1 mismatch (respectively P = .004 …
of severe aGVHD (P = .5), which was lower than pairs with >1 mismatch (respectively P = .004 …